Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Overview of attention for article published in Journal of Clinical Oncology, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 27 news outlets
blogs: 2 blogs
policy: 1 policy source
twitter: 58 X users
patent: 17 patents

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages
video: 1 YouTube creator
guideline: 4 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 323 Mendeley

So far, Altmetric has seen 4 posts from 2 blogs.

Tumor-infiltrating lymphocyte therapy compared to ipilimumab in advanced melanoma

Physician's Weekly, 23 Dec 2022

1 .Tumor-infiltrating lymphocytes therapy shows improvements in PFS when compared to…

#VisualAbstract: Tumor-infiltrating lymphocyte therapy compared to ipilimumab in advanced melanoma

Physician's Weekly, 23 Dec 2022

1 .Tumor-infiltrating lymphocytes therapy shows improvements in PFS when compared to…

Tumor-Infiltrating Lymphocytes for Advanced Melanoma Outperform Ipilimumab

Physician's Weekly, 14 Sep 2022

Second-line treatment with tumor-infiltrating lymphocytes (TILs) improves progression-free survival (PFS) compared with…

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma.

Clinowl, 11 May 2021

Effective treatment options are limited for patients with advanced (metastatic or unresectable) melanoma who progress after…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.